Correlation Between Eastman Chemical and Tandem Diabetes

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eastman Chemical and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eastman Chemical and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eastman Chemical and Tandem Diabetes Care, you can compare the effects of market volatilities on Eastman Chemical and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eastman Chemical with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eastman Chemical and Tandem Diabetes.

Diversification Opportunities for Eastman Chemical and Tandem Diabetes

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Eastman and Tandem is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Eastman Chemical and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and Eastman Chemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eastman Chemical are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of Eastman Chemical i.e., Eastman Chemical and Tandem Diabetes go up and down completely randomly.

Pair Corralation between Eastman Chemical and Tandem Diabetes

Considering the 90-day investment horizon Eastman Chemical is expected to generate 0.39 times more return on investment than Tandem Diabetes. However, Eastman Chemical is 2.57 times less risky than Tandem Diabetes. It trades about 0.05 of its potential returns per unit of risk. Tandem Diabetes Care is currently generating about 0.0 per unit of risk. If you would invest  7,881  in Eastman Chemical on August 28, 2024 and sell it today you would earn a total of  2,703  from holding Eastman Chemical or generate 34.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eastman Chemical  vs.  Tandem Diabetes Care

 Performance 
       Timeline  
Eastman Chemical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Eastman Chemical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating primary indicators, Eastman Chemical may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Tandem Diabetes Care 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eastman Chemical and Tandem Diabetes Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eastman Chemical and Tandem Diabetes

The main advantage of trading using opposite Eastman Chemical and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eastman Chemical position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.
The idea behind Eastman Chemical and Tandem Diabetes Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments